Stay updated on Veliparib Combo in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Veliparib Combo in NSCLC Clinical Trial page.

Latest updates to the Veliparib Combo in NSCLC Clinical Trial page
- Check4 days agoChange DetectedA notice about NIH’s transition from the term “Artificial Intelligence” to “Super Intelligence” appears above the existing 403 error page, and the site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1. The page still displays a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check32 days agoChange DetectedThe page now shows a 403 Forbidden error. It replaces the full study record content with a minimal header and a Home link.SummaryDifference20%

- Check39 days agoChange DetectedA new revision tag (Revision: v3.7.0) appears on the page, replacing the previous Revision: v3.6.6. This indicates the page has been updated to a newer version.SummaryDifference0.0%

- Check53 days agoChange DetectedRevision: v3.6.6 is now displayed in the page footer, replacing Revision: v3.6.5. This change reflects a site version update.SummaryDifference0.0%

- Check60 days agoChange DetectedThe study record now includes a funding attribution line, '2016 ( U.S. NIH Grant/Contract )', indicating NIH support alongside the study identifiers.SummaryDifference0.0%

Stay in the know with updates to Veliparib Combo in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Veliparib Combo in NSCLC Clinical Trial page.